Arrhythmia-induced Cardiomyopathy - a Prospective Observational Cohort Study
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnostic or suspicion of AiCM as presence of specified keyword in patient's file or as screened by colleagues of the internal medicine or cardiology clinics
• Signed study consent
• Patients with a reduced left-ventricular ejection fraction (LVEF ≤50%) or a reduction of 15% in the ejection fraction (EF) between two echocardiographies and a concomitant diagnosis of any arrhythmia likely to lead to AiCM within one year before or after diagnosis of the reduced LVEF from 2010-2021
Locations
Other Locations
Switzerland
University Hospital Basel, Department of Cardiology
RECRUITING
Basel
Contact Information
Primary
Patrick Badertscher, MD
patrick.badertscher@usb.ch
+41 61 556 58 23
Backup
Jeanne du Fay de Lavallaz, MD-PhD
jeanne.dufay@usb.ch
+41 61 328 76 44
Time Frame
Start Date: 2021-06-10
Estimated Completion Date: 2027-01
Participants
Target number of participants: 2700
Treatments
Patients with arrhythmia-induced cardiomyopathy (retrospective/prospective)
retrospective cohort and case-control study followed by a prospective observational cohort study.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Basel, Switzerland